Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BETA trial of tolperisone and biomarkers in acute low back pain
2019-001885-14Phase 3Completed
- Sponsor
- National Research, Development and Innovation Office
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of tolperisone in acute lumbago and Sciatica, sponsored by National Research, Development and Innovation Office. Started May 2019; status: completed.
02
Drugs
tolperisone
03
Conditions
acute lumbagoSciatica
Beyond the preview
Go deeper on 2019-001885-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001885-14.